Results 151 to 160 of about 41,818 (235)

Assessing the Impact of Crohn's Disease on Foot Health‐Related Quality of Life: A Case–Control Study

open access: yesInternational Wound Journal, Volume 23, Issue 6, June 2026.
ABSTRACT Crohn's disease (CD) is primarily characterised by chronic gastrointestinal inflammation; however, its systemic nature frequently leads to musculoskeletal complications. Among these, clinically significant foot pathologies can impair mobility and negatively impact patients' overall quality of life.
Juan Manuel Escudero‐Prados   +8 more
wiley   +1 more source

Myocellular adaptations to short‐term weighted wheel‐running exercise are largely conserved during C26‐tumour induction in male and female mice

open access: yesExperimental Physiology, Volume 111, Issue 6, Page 3039-3054, 1 June 2026.
Abstract This study investigated whether performing a translatable murine model of concurrent training after tumour induction affects adaptations in juvenile male and female tumour‐bearing mice. Male and female Balb/c mice were injected bilaterally with colon‐26 adenocarcinoma (C26) cells or PBS at 8 weeks of age.
Stavroula Tsitkanou   +10 more
wiley   +1 more source

The Georgian version of the Juvenile Arthritis Multidimensional Assessment Report (JAMAR). [PDF]

open access: yesRheumatol Int, 2018
Ioseliani M   +5 more
europepmc   +1 more source

Poster Sessions

open access: yes
HemaSphere, Volume 10, Issue S1, June 2026.
wiley   +1 more source

Publication Only

open access: yes
HemaSphere, Volume 10, Issue S1, June 2026.
wiley   +1 more source

The Farsi version of the Juvenile Arthritis Multidimensional Assessment Report (JAMAR). [PDF]

open access: yesRheumatol Int, 2018
Shafaie N   +8 more
europepmc   +1 more source

The Thai version of the Juvenile Arthritis Multidimensional Assessment Report (JAMAR). [PDF]

open access: yesRheumatol Int, 2018
Vilaiyuk S   +8 more
europepmc   +1 more source

The Hebrew version of the Juvenile Arthritis Multidimensional Assessment Report (JAMAR). [PDF]

open access: yesRheumatol Int, 2018
Uziel Y   +7 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy